CIK 0001159036
- Large accelerated filer
HALOZYME THERAPEUTICS, INC.
Sign in to watch- Ticker
- HALO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 880488686
- Phone
- +1 858-794-8889
- Business address
- 12390 EL CAMINO REAL, SAN DIEGO, CA, 92130
- Former names
- HALOZYME THERAPEUTICS INC, GLOBAL YACHT SERVICES INC
- 4 Shares withheld for taxes SVP, CHIEF FINANCIAL OFFICER gave up 12,894 shares (to pay taxes)
- 4 Shares withheld for taxes PRESIDENT AND CEO gave up 48,043 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale PRESIDENT AND CEO sold 50,000 shares at an average $77.07 ($3,853,503)
- 4 Grant or award Director acquired 889 shares (grant or award)
- 4 Planned sale Director sold 2,000 shares at $70.25 ($140,500)
- 4 Shares withheld for taxes SVP, CHIEF LEGAL OFFICER gave up 4,243 shares (to pay taxes)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale SVP, CHIEF OPERATING OFFICER sold 4,263 shares at $65.19 ($277,905)
- 4 Derivatives Options or other derivatives
- 4 Planned sale Director sold 829 shares at $71.60 ($59,356)
- 4 Planned sale PRESIDENT AND CEO sold 16,569 shares at an average $68.92 ($1,141,925)
- 4 Planned sale PRESIDENT AND CEO sold 60,000 shares at an average $69.47 ($4,167,930)
- 4 Planned sale Director sold 2,000 shares at $68.48 ($136,960)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Planned sale PRESIDENT AND CEO sold 60,000 shares at an average $71.86 ($4,311,745)
Page 3 of 39 · 774 filings